Although the randomized controlled trial (RCT) is the optimal design to determine a therapy’s safety and efficacy in many cases, it is unable to answer a broad constellation of questions healthcare stakeholders must answer to understand the value of a therapy in real-world medical practice.
Pragmatic clinical trials (PCTs) are designed to extend scientific evaluation beyond the limits of the RCT research setting and into the realm of real-world medical practice. For the life sciences industry, PCTs offer solutions to address the growing demands of care providers, payers and policy makers for high-quality evidence of therapeutic and economic value.
Join Mark Cziraky, Co-Founder and Vice President of Research at HealthCore, and Vince Willey, Principal Scientist at HealthCore, for a webinar exploring:
- The rationale and key characteristics of pragmatic clinical trials
- Design and infrastructure considerations for pragmatic clinical trials
- The opportunities, challenges, and lessons learned from real world examples of pragmatic clinical trials